What Researchers Did
Researchers summarized how hyperbaric oxygen therapy modulates the tumour microenvironment to influence the effectiveness of cancer immunotherapy.
What They Found
They found that hyperbaric oxygen therapy regulates the tumour microenvironment by improving tumour hypoxia, targeting hypoxia-inducing factors, and generating reactive oxygen species. These changes in the tumour microenvironment were identified as ultimately affecting the curative effect of immunotherapy.
What This Means for Canadian Patients
This research suggests that hyperbaric oxygen therapy could potentially enhance the effectiveness of immunotherapy for Canadian cancer patients. Future clinical applications might involve combining these treatments to improve patient outcomes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this review is the current scarcity of studies specifically investigating hyperbaric oxygen and immunotherapy.